ACR Convergence 2025| Video: Rheuminations on Milestones & Ageism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: liver

The Legacy of Amyloid: Infiltration Linked to Dementia, Rheumatic Disease

Simon M. Helfgott, MD  |  October 16, 2017

An Unforgettable Story Her name was unforgettable. Not only did we share our given names—Simon and Simone, but her French-Canadian surname was based on this appellation, too. I was the junior resident working on our hospital’s nephrology service when she was admitted for evaluation of progressively worsening kidney disease and an overall failure to thrive….

Filed under:ConditionsOpinionRheuminationsSpeak Out Rheum Tagged with:Amyloidosisbraincase reportClinicaldementiaDiagnosismortalityneuronoutcomepatient careplaquerheumatologistrheumatology

MACRA: Tips & Tools for Rheumatology Staff

From the College  |  October 4, 2017

All healthcare professionals who work in rheumatology had to start adapting to a new landscape of reporting and documentation on Jan. 1 of this year when the Medicare Access and Children’s Health Insurance Program (CHIP) Reauthorization Act, or MACRA, began. As the changeover continues, the Sunday ARHP session, Your New Role in the Era of…

Filed under:From the CollegePractice SupportQuality Assurance/Improvement Tagged with:2017 ACR/ARHP Annual MeetingMACRAMedicare Access and Children’s Health Insurance Program (CHIP) Reauthorization ActMIPSreporting and documentation

ACR Pursues Solutions for Flawed MIPS Infusion Regulations & Billing Codes

Mary Beth Nierengarten  |  October 4, 2017

While the latest version of the Republican-sponsored healthcare bill once again falters and its prospects of becoming the new law of the land fade, plenty of advocacy work is continuing on behalf of rheumatologists and rheumatology practices. The ACR, along with multiple partners, has renewed its push for regulatory relief in a number of areas…

Filed under:Legislation & Advocacy Tagged with:evaluation and management codesLocal Coverage Determination (LCD)Part B drug paymentsPart D biosimilarsprior authorizationpush for regulatory reliefQualified Clinical Data Registries (QCDRs)Regulatory Relief Coalition

Efficacy Studied Following Accelerated Drug Approvals

Michele B. Kaufman, PharmD, BCGP  |  October 2, 2017

In recent years, the number of drugs to receive accelerated FDA approval has increased. A new study examined whether these drugs have demonstrated efficacy in post-approval trials…

Filed under:Drug Updates Tagged with:acceleratedFDAFDA approvalU.S. Food and Drug Administration (FDA)

Advances in Education for Rheumatology Health Professionals: A Review & an Opportunity

Courtesy of the ARHP Practice Committee  |  September 22, 2017

Educational opportunities for health professionals are expanding. At this year’s Annual Meeting, don’t miss a historic joint session from the ARHP and the Canada-based Arthritis Health Professions Association about the advances in and effects of these educational opportunities on rheumatology…

Filed under:Professional Topics Tagged with:2017 ACR/ARHP Annual MeetingACR/ARHP Annual MeetingArthritis Health Professions AssociationAssociation of Rheumatology Professionals (ARP)Canadahealth professionalsInternational

Effectiveness of Tofacitinib with Methotrexate, Adalimumab Therapy Evaluated in Patients with RA

Thomas R. Collins  |  September 19, 2017

MADRID—Tofacitinib (a JAK inhibitor) used with methotrexate (MTX) is not inferior to adalimumab (a TNF inhibitor) in rheumatoid arthritis (RA) patients who’ve had an inadequate response to MTX alone, according to results of a Phase 3B/4 trial presented in a session at the Annual European Congress of Rheumatology (EULAR). The findings came in a one-year…

Filed under:ConditionsDrug UpdatesResearch RheumRheumatoid Arthritis Tagged with:adalimumabAnnual European Congress of RheumatologyClinicalDisease-modifying antirheumatic drugs (DMARDs)effectivenessEULARMedicationMethotrexateORAL Strategyoutcomepatient careRAResearchRheumatoid arthritisrheumatologytherapyTofacitinib

Skype-Based Biopsychosocial Treatments Help Save Physical Therapy Patients Time, Trouble

Elizabeth Hofheinz, MPH, MEd  |  September 19, 2017

It’s a bit ironic that when injured people are in pain—and their mobility is reduced—they are often expected to travel to a physical therapy clinic. For millions of people, such trips are a burden. In Australia, however, some patients are “letting movement come to them.” Novel research from The University of Melbourne shows that taking…

Filed under:Practice SupportResearch RheumTechnology Tagged with:biopsychosocialExerciseInternetonlinePain Managementpatient carePhysical TherapyPractice ManagementResearchstudyTreatment

Rheumatology Research Foundation Hosts 10th Annual Investigators’ Meeting in St. Louis

From the College  |  September 17, 2017

The Rheumatology Research Foundation hosted the 10th Annual Investigators’ Meeting in St. Louis, June 24–25. The meeting provides Foundation-funded investigators an opportunity to learn about recent findings and research projects, network, exchange ideas and collaborate on future projects. More than 30 rheumatology professionals were in attendance, with presentations from 21 investigators. James O’Dell, MD, professor…

Filed under:From the CollegeResearch Rheum Tagged with:cureinvestigatorsMeetingResearchRheumatoid arthritisrheumatologistRheumatology Research FoundationSt. LouisTreatment

Why We Advocate to Certain Congressional Committees over Others

From the College  |  September 5, 2017

The U.S. Congress refers to the bicameral legislature, consisting of the 435 voting and six non-voting members of the House of Representatives and the 100 members of the Senate. When we visit D.C. or express our policy positions to Congress, our message would ideally reach every member. The ultimate goal is to reach all 541…

Filed under:Legislation & AdvocacyProfessional Topics Tagged with:committees of jurisdictionEducationEnergy and Commerce CommitteeLabor and Pensions (HELP)LobbyingSenate Committee on HealthSenate Finance CommitteeU.S. CongressWays and Means Committee

CMS Announces 90% Cut to Obamacare’s Advertising Budget

Reuters Staff  |  September 4, 2017

WASHINGTON (Reuters)—The U.S. Centers for Medicare and Medicaid Services (CMS) said on Thursday it plans to spend $10 million on advertising for the upcoming Obamacare open enrollment period that starts in November, a sharp cut from the $100 million spent last year. The agency also said it will cut funding for so-called navigators, who help…

Filed under:Legislation & AdvocacyProfessional Topics Tagged with:Centers for Medicare & Medicaid Services (CMS)Health InsuranceObamacareTrump administrationU.S. health insurers

  • « Previous Page
  • 1
  • …
  • 64
  • 65
  • 66
  • 67
  • 68
  • …
  • 128
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences